Skip to main content
. Author manuscript; available in PMC: 2022 Jun 7.
Published in final edited form as: Obstet Gynecol. 2019 Sep;134(3):573–580. doi: 10.1097/AOG.0000000000003404

Table 4.

Unadjusted and Adjusted Association between method of contraception and trichomoniasis

Contraceptive
method
(time-varying)
Non-
Trichomoniasis
intervals (%)
Trichomoniasis
intervals (%)
cHR
(95% CI)
aHR#
(95% CI)
 Non-hormonal 5626 (77%) 489 (85%) Ref Ref
 DMPA 659 (9%) 18 (3%) 0.38*** (0.22-0.65) 0.43** (0.25-0.74)
 Implant 45 (1%) 2 (0%) 0.62 (0.10-3.73) ----
 OCPs 981 (13% 65 (11%) 0.87 (0.63-1.20) 0.95 (0.7-1.31)

OCP: oral contraceptive pill; IUD: copper intrauterine device; DMPA: Depot Medroxyprogesterone Acetate; cHR: crude hazard ratio; aHR: adjusted hazard ratio; CI: confidence interval

#

Controlling for women’s HIV status, pregnancy status, breastfeeding, active genital ulcer, bacterial vaginosis, and vaginal candidiasis

no method, condoms, permanent (excludes copper intrauterine devices)

*

p-value<0.05

**

p-value<0.01

***

p-value<0.001.

Number of events in Implant group too few to allow for adjusted estimates